Seguir
Ruth Müller
Ruth Müller
Department of Science, Technology & Society, School of Social Sciences and Technology, Department of
Dirección de correo verificada de tum.de - Página principal
Título
Citado por
Citado por
Año
Unsustainable Growth, Hyper-Competition, and Worth in Life Science Research: Narrowing Evaluative Repertoires in Doctoral and Postdoctoral Scientists’ Work and Lives
M Fochler, U Felt, R Müller
Minerva 54 (2), 175-200, 2016
2652016
Racing for what? Anticipation and acceleration in the work and career practices of academic life science postdocs
R Müller
Forum Qualitative Sozialforschung/Forum: Qualitative Social Research 15 (3), 2014
201*2014
Exploring the epistemic impacts of academic performance indicators in the life sciences
R Müller, S de Rijcke
Research Evaluation 26 (3), 157-168, 2017
1632017
Mapping the new molecular landscape: social dimensions of epigenetics
M Pickersgill, J Niewöhner, R Müller, P Martin, S Cunningham-Burley
New genetics and society 32 (4), 429-447, 2013
1552013
Embedded ethics: a proposal for integrating ethics into the development of medical AI
S McLennan, A Fiske, D Tigard, R Müller, S Haddadin, A Buyx
BMC Medical Ethics 23 (1), 1-10, 2022
1372022
Of rats and women: Narratives of motherhood in environmental epigenetics
M Kenney, R Müller
BioSocieties, 1-24, 2016
1352016
Postdoctoral life scientists and supervision work in the contemporary university: A case study of changes in the cultural norms of science
R Müller
Minerva 52 (3), 329-349, 2014
1202014
An embedded ethics approach for AI development
S McLennan, A Fiske, LA Celi, R Müller, J Harder, K Ritt, S Haddadin, ...
Nature Machine Intelligence 2 (9), 488-490, 2020
1122020
Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization
G Hudelist, CF Singer, E Kubista, M Manavi, R Mueller, K Pischinger, ...
Histopathology 45 (6), 633-637, 2004
1102004
The biosocial genome?: Interdisciplinary perspectives on environmental epigenetics, health and society
R Müller, C Hanson, M Hanson, M Penkler, G Samaras, L Chiapperino, ...
EMBO reports 18 (10), 1677-1682, 2017
992017
Agential conversations: Interviewing postdoctoral life scientists and the politics of mundane research practices
R Müller, M Kenney
Science as Culture 23 (4), 537-559, 2014
942014
Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based …
G Hudelist, WJ Köstler, J Attems, K Czerwenka, R Müller, M Manavi, ...
British journal of cancer 89 (6), 983-991, 2003
892003
Collaborating in life science research groups: The question of authorship
R Müller
Higher Education Policy 25 (3), 289-311, 2012
882012
Interleukin 1α and tissue-lytic matrix metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis
G Hudelist, H Lass, J Keckstein, I Walter, F Wieser, R Wenzl, R Mueller, ...
Human Reproduction 20 (6), 1695-1701, 2005
882005
DOHaD in science and society: emergent opportunities and novel responsibilities
M Penkler, M Hanson, R Biesma, R Müller
Journal of developmental origins of health and disease 10 (3), 268-273, 2019
802019
Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic …
WJ Köstler, G Hudelist, W Rabitsch, K Czerwenka, R Müller, CF Singer, ...
Journal of cancer research and clinical oncology 132 (1), 9-18, 2006
662006
Re-disciplining Academic Careers? Interdisciplinary Practice and Career Development in a Swedish Environmental Sciences Research Center
R Müller, W Kaltenbrunner
Minerva 57 (4), 479-499, 2019
642019
Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations
G Hudelist, T Wagner, M Rosner, A Fink-Retter, D Gschwantler-Kaulich, ...
Endocrine-related cancer 14 (4), 1053-1062, 2007
642007
Her‐2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab‐based therapy in patients with metastatic breast cancer
G Hudelist, WJ Köstler, K Czerwenka, E Kubista, J Attems, R Müller, ...
International journal of cancer 118 (5), 1126-1134, 2006
612006
Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors
CF Singer, G Hudelist, W Lamm, R Mueller, K Czerwenka, E Kubista
Endocrine-related cancer 11 (4), 861-869, 2004
552004
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20